Answer: It is not mandatory, though relevant policies are encouraging this practice. Per the latest NMPA Announcement issued in 2025, holders of imported medical device registration certificates may establish foreign-invested enterprises (or enterprises under the same actual controller) in China to manufacture products with valid import registration certificates, and enjoy priority review and approval. This creates a compliant and efficient channel for switching imported products to domestic production, which helps shorten supply lead times and reduce tariff costs.